Role of regulatory T cell populations in controlling graft vs host disease

scientific article published on July 2011

Role of regulatory T cell populations in controlling graft vs host disease is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BEHA.2011.05.006
P932PMC publication ID3176418
P698PubMed publication ID21925098
P5875ResearchGate publication ID51649527

P50authorRobert S. NegrinQ110528996
P2860cites workCD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsQ29618394
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemiaQ33629928
Transplantation tolerance induced by "mega dose" CD34+ cell transplantsQ33856068
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationQ34162461
CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host diseaseQ34525987
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanismQ35866143
Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host diseaseQ36368026
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantationQ36370863
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantationQ36384707
In vivo imaging using bioluminescence: a tool for probing graft-versus-host diseaseQ36488762
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia responseQ40651436
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantationQ44408941
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.Q53589050
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotypeQ77437408
The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethalityQ78033315
Protective conditioning for acute graft-versus-host diseaseQ81279975
P433issue3
P304page(s)453-457
P577publication date2011-07-01
P1433published inBest Practice and Research: Clinical HaematologyQ15755888
P1476titleRole of regulatory T cell populations in controlling graft vs host disease
P478volume24

Reverse relations

cites work (P2860)
Q36555546Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence
Q38734173Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.
Q36431047Prevention of graft-vs.-host disease
Q37707135Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

Search more.